Carrington Laboratories

With more than $70 million in basic and clinical research, Carrington Laboratories has accomplished the centuries-old goal of producing proven, quality products from the inner-leaf gel of the Aloe vera plant.
Carrington's scientific, patented process guarantees that specific measured amounts of Aloe vera can be found in every Carrington product. Through Carrington's wholly owned subsidiary, Caraloe Inc., the company produces nutraceutical raw materials.
Carrington's consumer products division, AloeCeuticals™, was launched in July 1999. AloeCeuticals™ are the only Aloe vera based products on the market that contain stabilized and standardized concentrations of complex carbohydrates and carry DSHEA claims that they enhance or promote the body's immune function.

Activity:

- Manufacturing

Product / Technology type(s) covered:

- Pharmaceuticals / Therapeutics
- Phyto
- Nutritionals / Vitamins

Therapeutic targets:

Markets Covered

a. HeadQuarter:

b. Continent(s) active:

c. Countries active:

Corporate data:

Number of Employees:

Turnover:

Amount:	Year:	Currency:

Year founded: